trial · primary record
Placebo Cohort 1 (1.5 mg/kg/dose) only
Pulmonary Arterial Hypertension PAH
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 96 |
| Primary completion | 2027-11-30 |
| Primary endpoint | Safety and tolerability of ZMA001 in healthy subjects |
| Registry ID | NCT05967299 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:30:47.501Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05967299
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.